While aripiprazole alone is not a common cause of serotonin syndrome,8 its metabolism via CYP2D6 and CYP3A4 suggests a possible interaction with residual DXM metabolites, which may have delayed serotonin clearance and increased the risk of toxicity. Here, CYP3A4 is linked to serotonin syndrome.